Key Developments: - Cambridge Technology (06166): Offered H-shares at HKD 68.88 per share. - SANY Heavy Industry (06031): Offered H-shares at HKD 21.30 per share. - Hansoh Pharma (01276): Two formulations of Gliclazide Metformin Extended-Release Tablets (Ⅰ) and (Ⅱ) approved for market. - Shanghai Pharmaceutical (02607): Subsidiary becomes the holder of market license for Amisulpride Orodispersible Tablets. - Fosun Pharma (02196): Delasertib Tablets and Delasertib Granules registered. - WuXi AppTec (02359): Plans to sell 100% stakes in Kande Hongyi and Jinshi Pharmaceuticals. - Henglifeng Holdings (00643): Received about 79.20% discount on total bid. Resumes trading on October 27.

Performance Reports: - Chifeng Gold (06693): Third-quarter net profit of RMB 0.951 billion, a year-on-year increase of 140.98%. - WuXi AppTec (02359): First three quarters net profit at RMB 12.076 billion, up 84.84% year-on-year. - Huaxin Cement (06655): First three quarters net profit of RMB 2.004 billion, a 76.01% increase year-on-year. - CMOC (03993): Reports net profit of approximately RMB 14.28 billion for the first three quarters, a year-on-year growth of 72.61%. - Goldwind Technology (02208): First three quarters net profit at approximately RMB 2.584 billion, a growth of 44.21%. - CITIC Securities (06030): First three quarters net profit approximately RMB 23.159 billion, up 37.86% year-on-year. - KINGDEE INT'L (00268): Continues to deepen its core strategy of "AI-First, Subscription-First, Globalization," with subscription service annual recurring revenue of approximately RMB 3.86 billion in the first three quarters, up 18% year-on-year. - China Nonferrous Mining (01258): Estimates net profit attributable to owners of approximately USD 356 million in the first three quarters, an increase of approximately 13% year-on-year. - Chongqing Bank (01963): First three quarters net profit of RMB 4.879 billion, an increase of 10.19% year-on-year. - China Resources Cement (01313): First three quarters profit attributable to shareholders of RMB 0.331 billion, a growth of 7.3%. - China Shenhua (01088): Reports net profit of RMB 41.366 billion for the first three quarters, down 13.8% year-on-year. - Haohai Biological Technology (06826): First three quarters net profit around RMB 0.305 billion, a decrease of 10.63% - Great Wall Motors (02333): Reports third-quarter net profit of RMB 2.298 billion, down 31.23%. - China Heartland Chemical (01866): Reports first three quarters net profit around RMB 0.8 billion, down 47.86%. - China National Building Material (03323): First three quarters net profit of RMB 2.96 billion. - GAC GROUP (02238): Reports net loss of approximately RMB 4.312 billion for the first three quarters, a move from profit to loss year-on-year. - China Overseas Development (00688): Reports revenue of RMB 103 billion for the first three quarters, with operating profit of RMB 13.15 billion. - Sea Fresco International (01308): First three quarters revenue of approximately USD 2.459 billion, up about 16.6% year-on-year. - China Energy Construction (03996): New contracts signed in the first three quarters amounting to RMB 999.775 billion, up 0.4% year-on-year. - Li Ning (02331): Third-quarter e-commerce virtual store business sees high double-digit growth. - China Power (02380): Total consolidated power sale in September reached 9.4657 million MWh.